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Erythema migrans, the characteristic skin manifes-
tation of acute Lyme borreliosis, is a self-limited
lesion. In contrast, acrodermatitis chronica atrophi-
cans, the typical cutaneous manifestation of late
Lyme borreliosis, is a chronic skin condition. In an
effort to understand pathogenic factors that lead to
different outcomes in dermatoborrelioses, skin
biopsy samples from 42 patients with erythema
migrans and 27 patients with acrodermatitis chronica
atrophicans were analyzed for mRNA expression of
®ve pro-in¯ammatory cytokines (tumor necrosis
factor a, interleukin-1b, interleukin-6, interferon-g,
and interleukin-2) and two anti-in¯ammatory cyto-
kines (interleukin-4 and interleukin-10) by in situ
hybridization with cytokine-speci®c riboprobes.
Among the 27 patients who had erythema migrans
alone with no associated signs or symptoms, the
major cytokines expressed in perivascular in®ltrates
of T cells and macrophages were the pro-in¯am-
matory cytokine interferon-g and the anti-in¯am-
matory cytokine interleukin-10. In the 15 erythema
migrans patients who had associated signs and symp-
toms, including headache, elevated temperature,
arthralgias, myalgias, or fatigue, a larger number of
macrophages and greater expression of macrophage-
derived pro-in¯ammatory cytokines, tumor necrosis
factor a, interleukin-1b, and interleukin-6, were also
found. In comparison, in®ltrates of T cells and
macrophages in the skin lesions of acrodermatitis
chronica atrophicans patients had very little or no
interferon-g expression. Instead, they usually
expressed only the pro-in¯ammatory cytokine tumor
necrosis factor a and the anti-in¯ammatory cytokine
interleukin-4. Thus, the activation of pro-in¯amma-
tory cytokines in erythema migrans lesions, particu-
larly interferon-g, seems to be important in the
control of the spirochetal infection. In contrast, the
restricted pattern of cytokine expression in acro-
dermatitis chronica atrophicans, including the lack
of interferon-g, may be less effective in spirochetal
killing, resulting in the chronicity of this skin lesion.
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L
yme borreliosis (LB) is a complex multisystem disease
caused by infection with the tick-borne spirochete
Borrelia burgdorferi sensu lato (Steere et al, 1983a). Three
pathogenic borrelial genospecies, B. burgdorferi sensu
stricto, B. afzelii, and B. garinii, are known to cause
human LB (Baranton et al, 1992). To date, all North American
strains have belonged to the ®rst group, B. burgdorferi sensu stricto.
All three genospecies have been found in Europe, but most isolates
there have been B. afzelii or B. garinii strains. These differences may
account for certain regional variations in the clinical picture of the
infection (Anthonissen et al, 1994; Picken et al, 1998).
Erythema migrans (EM), the characteristic expanding skin lesion
of acute LB, is self-limited in weeks to months (Steere et al, 1983b;
AÊ sbrink and Olsson, 1985; AÊ sbrink and Hovmark, 1988). In
contrast, acrodermatitis chronica atrophicans (ACA), the typical
skin manifestation of late LB, is a chronic and usually progressive
skin condition that does not resolve spontaneously. It starts with an
in¯ammatory phase and progresses slowly to an atrophic phase
(AÊ sbrink and Hovmark, 1988; Weber et al, 1993). In a previous
study in Austria,1 as in all of Europe, B. afzelii is most often
recovered from EM lesions, and ACA is almost always due to
infection with this borrelial species (Wienecke et al, 1994; Picken
et al, 1998; Strle et al, 1999). A variety of transient, nonspeci®c signs
and symptoms may occur with European EM, including elevated
temperature, lymphadenopathy, arthralgias, myalgias, or fatigue,
but they usually do not suggest spread of the spirochete to speci®c
organs (Weber and Neubert, 1986; AÊ sbrink and Hovmark, 1988).
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In contrast, in the U.S.A., where EM is caused by B. burgdorferi
sensu stricto infection, faster spreading of skin lesions is frequently
seen (Strle et al, 1999), often accompanied by signs and symptoms,
such as headache and neck stiffness or multiple skin lesions, that
suggest hematogenous dissemination of the spirochete to other
organ systems (Steere et al, 1983b; Berger, 1984; Strle et al, 1999).
In Europe, the most common extracutaneous complications of
ACA are arthropathy and peripheral neuropathy restricted to the
affected limb (AÊ sbrink and Hovmark, 1988), whereas in the U.S.A.
ACA is almost never seen.
Cytokines, which are important regulators and effectors of the
immune response, in¯uence the outcome of infectious and
autoimmune diseases. The importance of these responses in the
outcome of B. burgdorferi infection has been shown to have a
genetically determined component in inbred strains of mice. When
infected experimentally with B. burgdorferi, C3H mice develop
severe arthritis, whereas BALB/c mice develop only mild arthritis
(Barthold et al, 1990; Schaible et al, 1991; Yang et al, 1994). These
strain-related differences are associated with polarized cytokine
patterns and differences in spirochete burden in infected tissues.
When infected with the spirochete, C3H mice, which have a high
spirochete burden (Yang et al, 1994), produce gradually increasing
amounts of interferon-g (IFN-g) with low to absent interleukin-4
(IL-4) levels, a Th1 pattern of cytokine production (Keane-Myers
and Nickell, 1995; Matyniak and Reiner, 1995; Kang et al, 1997).
BALB/c mice initially have high levels of IFN-g, which probably
accounts for their low spirochete burden, but they switch to the
production of IL-4, a Th2 cytokine pattern (Keane-Myers and
Nickell, 1995; Matyniak and Reiner, 1995; Kang et al, 1997),
which is important in the resolution of joint in¯ammation. In
patients with Lyme arthritis, cultured peripheral blood or synovial
¯uid mononuclear cells produced high amounts of IFN-g and
tumor necrosis factor a (TNF-a), but little or no IL-4 (Yssel et al,
1991; Yin et al, 1997; Gross et al, 1998; Chen et al, 1999). The
reactivity of T cells and the production of pro-in¯ammatory
cytokines were greater in synovial ¯uid than in peripheral blood
(Gross et al, 1998). Moreover, the severity of arthritis correlated
directly with the ratio of Th1 to Th2 cells in synovial ¯uid, such
that the higher the number of Th1 cells, the more severe the joint
swelling (Gross et al, 1998). In the synovial membrane of Lyme
arthritis patients, mRNA expression of pro-in¯ammatory cyto-
kines, including IFN-g, TNF-a, and IL-1b, was predominant, but
mRNA for anti-in¯ammatory cytokines was found as well (Yin
et al, 1997; Harjacek et al, 2000). In neuroborreliosis, cultured
mononuclear cells from the peripheral blood and cerebrospinal
¯uid produced primarily IFN-g, whereas IL-4 production was
strikingly low (Wang et al, 1995; Oksi et al, 1996; Ekerfelt et al,
1997). Secretion of IFN-g was most pronounced in cerebrospinal
¯uid (Wang et al, 1995; Ekerfelt et al, 1997). Cytokine pro®les have
not yet been determined in patients with skin manifestations of LB,
however, including in those with EM or ACA.
In an effort to understand pathogenic factors that lead to different
outcomes in dermatoborrelioses, we used in situ hybridization
(ISH) with cytokine-speci®c riboprobes to analyze cytokine
responses in patients with EM, a self-limited skin lesion, compared
to those with ACA, a chronic, progressive lesion that does not
resolve spontaneously.
MATERIALS AND METHODS
Patients In 1997±8, we carried out a retrospective study of cytokine
pro®les of lesional skin in patients with EM or ACA. The study subjects
consisted of 42 patients with EM (median age 43.5 y; 29 males and 13
females) and 27 patients with ACA (median age 63 y; seven males and 20
females) seen between June 1993 and December 1996 at the Department of
Dermatology in Graz, Austria, for whom biopsy specimens and complete
clinical data were available. Patients who had been treated with antibiotics
prior to sampling or patients with conditions (e.g., atopy) or medications
(e.g., nonsteroidal anti-in¯ammatory drugs or corticosteroids) that could
potentially in¯uence the status of the immune system were not included.
EM was de®ned clinically as an expanding, sharply demarcated
erythema, sometimes with partial central clearing, of at least 5 cm in
diameter (Stanek et al, 1996). Of the 42 study patients with EM, 16 (38%)
had IgM and/or IgG antibody responses to B. burgdorferi, using puri®ed,
native ¯agella of B. afzelii, strain DK-1, as the test antigen (Dako Lyme
Borreliosis ELISA Kit; Dako, Glostrup, Denmark) (Hansen et al, 1988). In
addition, in 14 of 29 patients tested (48%), B. burgdorferi DNA was detected
in lesional skin, using nested polymerase chain reaction (PCR) with two
oligonucleotide primer pairs, as previously described (Wienecke et al,
1993). Altogether, 34 of 42 patients (81%) with EM had serologic and/or
PCR evidence of borrelial infection. The remaining eight patients with
negative laboratory results had the characteristic clinical appearance of EM.
Speciation of B. burgdorferi sensu lato subtypes was not done in the PCR-
positive EM patients.
ACA was de®ned clinically as a doughy bluish-red swelling, with or
without signs of atrophy, on the extensor surfaces of the extremities (Stanek
et al, 1996). All 27 study patients (100%) with ACA had a positive serologic
test result for IgG antibodies to B. burgdorferi. PCR testing was not done in
these patients.
Preparation of skin specimens Four millimeter punch biopsy
specimens were taken from all patients from the active border of EM
lesions or from the area of ACA lesions with the most prominent signs of
in¯ammation. For comparison, we used 4 mm punch biopsy specimens
obtained from seven EM patients from clinically uninvolved skin in the
area opposite the site of the EM lesion. All samples were placed
immediately in 4% formaldehyde/phosphate-buffered saline (PBS) and
®xed overnight, dehydrated in graded ethanol, and embedded in paraf®n.
From each sample, serial sections of 4 mm were cut for histopathology and
serial sections of 5 mm for immunohistochemistry (IHC) and ISH.
Histopathology and IHC In all patients, serial sections were stained
with hematoxylin and eosin for histopathologic examination. In a subset of
patients with EM or ACA in whom enough tissue was available, the
expression of leukocyte differentiation antigens CD3 (T cells), CD20 (B
cells), and CD68 (macrophages) was determined, using the avidin-biotin-
peroxidase complex method (Vectastain ABC Elite Kit; Vector
Laboratories, Burlingame, CA). For IHC, tissue sections mounted on
Superfrost Plus slides (Fisher Scienti®c, Pittsburgh, PA) were deparaf®nized
with xylene and rehydrated through a decreasing ethanol series.
Enhancement of immunoreactivity was achieved by microwave heating
of the sections in 10 mM sodium citrate (pH 6.0). For CD3 and CD68,
additional pretreatment with proteinase K (5 mg per ml) for 20 min was
performed, followed by immersion in 4% paraformaldehyde/PBS. Non-
speci®c binding was blocked using normal horse serum diluted 1:100 in
PBS for 20 min. Sections were then incubated with a primary polyclonal
rabbit antibody to CD3 (1:10 dilution in 2% bovine serum albumin/PBS)
or monoclonal mouse antibodies to CD20 (1:100) or CD68 (1:100) for
30 min (Dako USA, Carpinteria, CA). Binding was detected with the
universal biotinylated horse antimouse/rabbit IgG secondary antibody
(Vector) diluted 1:50 in PBS containing normal horse serum for 30 min.
The avidin-biotin-horseradish peroxidase complex (1:250 dilution) was
then applied for 30 min. Sections were developed for 5 min with 3,3¢-
diaminobenzidine tetrahydrochloride as chromogenic substrate in H2O2,
counterstained with hematoxylin, and mounted in an aqueous medium.
As negative controls, nonspeci®c rabbit or mouse IgG antibodies
(Vector) were used instead of the primary antibodies. As positive controls,
the respective primary antibodies were applied to tissue sections of in¯amed
tonsils (a gift from Dr. P. Kwan, Department of Pathology, Tufts
University, Boston, MA). All controls yielded the expected negative or
positive results.
Evaluation of IHC was performed by one blind observer using a Zeiss
light microscope (Carl Zeiss, Thornwood, NY). The entire tissue section
was examined under 4003 magni®cation. The percentage of cells positive
for a respective leukocyte marker was estimated relative to the total number
of in®ltrating cells. Positivity was graded on a scale from 0 to 3 as follows: 0,
all in®ltrating cells negative; 1, up to a third of all cells positive; 2, between
one-third and two-thirds of all cells positive; 3, more than two-thirds of all
cells positive.
RNA probes In each patient, the expression of mRNA for various pro-
in¯ammatory (TNF-a, IL-1b, IL-6, IFN-g, IL-2) and anti-in¯ammatory
(IL-4, IL-10) cytokines was determined in skin biopsy samples by ISH with
cytokine-speci®c riboprobes. To generate the speci®c antisense and sense
probes, coding region cDNA fragments, which were kindly provided by
Dr. P. Bucy (University of Alabama, Birmingham, AL), were subcloned
into pBluescript vectors (Stratagene, La Jolla, CA). The cDNA fragments
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correspond to the following nucleotides of the respective human full-length
cytokine sequences: TNF-a, 344±917 (574 bp); IL-1b, 445±1055 (611 bp);
IL-6, 19±1128 (1110 bp); IFN-g, 220±1193 (974 bp); IL-2, 145±800
(656 bp); IL-4, 64±518 (455 bp); and IL10, 411±1410 (1000 bp). GenBank
accession numbers for these sequences are as follows: TNF-a, M10988; IL-
1b, M15330; IL-6, M14584; IFN-g, X13274; IL-2, V00564; IL-4,
M13982; IL10, M57627. The sequences of the probes were con®rmed
(personal communication, Dr. P. Bucy, University of Alabama). For
replication, cDNA-containing plasmids were transformed into competent
Escherichia coli DH10B cells (Life Technologies, Gaithersburg, MD).
Plasmid DNA was then puri®ed from transformants (Wizard Plus
Minipreps DNA Puri®cation System; Promega, Madison, WI), digested
with restriction endonucleases, and fractionated by agarose gel
electrophoresis to screen for the presence of the appropriate insert.
Following linearization of the plasmids with the appropriate restriction
enzymes, transcription reactions were performed using T3 or T7
polymerases in the presence of digoxigenin-labeled UTP (SP6/T7 DIG
RNA Labeling Kit; Boehringer Mannheim, Indianapolis, IN) to obtain
antisense and sense riboprobes. The size of the transcribed RNA was tested
by agarose gel electrophoresis. Labeling ef®ciency was determined on dot
blots by comparing serial dilutions of the digoxigenin-labeled probe with a
prelabeled control using chemiluminescent detection with antidigoxigenin
Fab fragments conjugated to alkaline phosphatase, according to the
manufacturer's protocol (Boehringer).
ISH ISH was performed with modi®cations of previously described
methods (Lan et al, 1996). Serial tissue sections were mounted on silane-
coated Superfrost Plus slides (Fisher) and dried for 2 h at 60°C. Sections
were deparaf®nized with xylene and rehydrated through graded ethanol.
Following treatment with 0.1 M glycine and permeabilization with 0.3%
Triton X-100, the slides were placed in 10 mM sodium citrate (pH 6.0) and
brought to the boil three times in a microwave oven (600 W). Sections
were then incubated with proteinase K (5 mg per ml) for 20 min and
immersed in 4% paraformaldehyde/PBS for 5 min, followed by ethanol
dehydration. Thereafter, 25 ml of hybridization solution (40% formamide, 2
3 sodium citrate/chloride buffer, 1 3 Denhardt's solution, 10% dextran
sulfate, 0.01 M dithiothreitol, 1 mg yeast tRNA per ml, and 1 mg sheared,
denatured salmon sperm DNA per ml) containing 5 ng of the respective
heat-denatured antisense or sense riboprobe were applied to each tissue
section and covered with a cover slip. Hybridization was carried out
overnight at 42°C in a microheating system with a moist environment
(TruTemp; Robbins Scienti®c, Sunnyvale, CA). All steps were carried out
with precautions to prevent RNAse degradation, including use of separate
glassware and autoclaved solutions prepared in diethylpyrocarbonate-
treated water. After hybridization, sections were washed under stringent
conditions including treatment with 20 mg per ml RNAse A (Boehringer).
For detection of hybridized probes, sections were blocked with normal
horse serum and incubated with a biotinylated monoclonal mouse
antidigoxin antibody (1:1000 dilution) (Sigma, St. Louis, MO) for
60 min at 37°C. The next incubation was in avidin-biotin-peroxidase
complex (Vector), followed by the substrate, diaminobenzidine-H2O2.
Sections were counterstained with hematoxylin and mounted in an
aqueous medium.
To document hybridization speci®city, the following control experi-
ments were performed. Duplicate sections on the same slide were always
stained with antisense or sense probes for the respective cytokine mRNA.
Staining with the sense probes gave only uniform background reactions
(Fig 4f). Application of hybridization buffer with no probe yielded the
expected negative results (Fig 1a). Investigation of the seven samples from
normal skin disclosed a minimal constitutive production of cytokines
(Fig 1b). As positive controls, tissue sections of in¯amed tonsils (a gift from
Dr. P. Kwan, Department of Pathology, Tufts University, Boston, MA)
were subjected to ISH with the seven cytokine-speci®c riboprobes.
Localization of the respective signals was found to agree with that
previously determined at the protein level (Andersson et al, 1994) (Fig 1c).
Quanti®cation of cytokine-producing cells Evaluation of all slides
was performed in a blind fashion by the same examiner using a light
microscope (Zeiss) with a rectangular morphometric grid. First, the entire
slide was scanned at 1003 magni®cation proceeding from the top to the
bottom of the section to select dermal areas with the most intense
in¯ammatory in®ltrates. These areas were then examined at 4003
magni®cation to ascertain the distribution of cytokine-positive cells
within the in¯ammatory in®ltrates. Next, the number of cytokine-
producing cells in these areas was counted in 15 randomly chosen high-
power ®elds per specimen under 10003 magni®cation, the magni®cation
at which positive cells were best discernible. Due to the distribution of the
in®ltrate, about two-thirds of the analyzed ®elds were located within the
upper dermis and one-third of the ®elds within the lower dermis, including
central as well as peripheral zones of the section. In preliminary studies, we
found that the analysis of as many as 50 high-power ®elds yielded similar
results to 15 high-power ®elds. Cytokine-positive cells were de®ned as cells
with a distinct local perinuclear (ring-like) granular staining. Within the
same high-power ®elds, the number n of in¯ammatory cells seen on a line
that bisected the microscopic ®eld was counted, and the total number N of
cells in that ®eld was calculated according to the formula N = (n 3 p/4)2.
This method has previously been shown to be an accurate estimate of the
actual number of cells per high-power ®eld (Simpson et al, 1992). For each
cytokine, the percentage of cytokine-positive cells per total number of
in¯ammatory cells from all 15 high-power ®elds was calculated for each
patient, and this value was used for statistical analysis.
Statistics For analysis, the patients were divided into three groups: those
who had EM alone without associated signs and symptoms, those who had
EM with associated signs and symptoms, and those who had ACA. The
distribution of values between the groups in duration of EM, expression of
leukocyte differentiation antigens, and percentage of cells expressing
mRNA for each cytokine was compared by Kruskal±Wallis test, a
nonparametric statistical method. In the tables, the median values (half of
the samples) are shown as well as the ®rst and third quartile values (one-
quarter and three-quarters of the values), which is called the interquartile
range. In addition, the percentage of patients with at least one cell
expressing mRNA for a given cytokine and the correlation of cytokine data
with PCR results were compared between groups using the c2 test.
Cytokine mRNA expression in lesional skin was compared with disease
duration before sampling in both EM groups and the ACA group using the
Spearman rank correlation coef®cient. p-values are two-tailed.
RESULTS
Clinical features Of the 42 patients with EM, 39 (93%) had
solitary homogenous or ring-like erythematous lesions with a
median diameter of 14 cm (range, 6±50 cm), and three (7%) had
multiple EM lesions. Twenty-seven of the 42 patients (64%) had
EM alone with no associated signs or symptoms. The remaining 15
patients (36%) had EM with associated signs and symptoms,
including headache, elevated temperature, arthralgias, myalgias, or
fatigue. Four of these 15 patients had clinical evidence of
disseminated infection: three had multiple EM lesions, in two
instances accompanied by intense headache and neck stiffness, and
the fourth patient had polyneuritis. The median duration of EM
before biopsy was 7 d (range, 3±60 d) in the group without
associated symptoms, and 18.5 d (range, 4±60 d) in the group with
associated symptoms. This difference was not statistically
signi®cant, however (p = 0.7).
Of the 27 patients with ACA, eight (30%) had skin changes for
0±3 mo (acute stage), ten (37%) for 4±12 mo (subacute stage), and
nine (33%) for more than 12 mo (chronic stage). The range of
disease duration in all ACA patients was 1±156 mo (median, 7 mo).
Ten patients (37%) had a distal neuropathy within the area of the
affected skin, but none had signs or symptoms extending beyond
the skin lesion.
Histopathologic ®ndings On histopathologic examination, all
specimens were consistent with the diagnosis of EM or ACA
(Duray and Chandler, 1997). EM lesions were characterized by
mild to marked perivascular in®ltrates in the papillary more than
the reticular dermis (Fig 2a). The in®ltrates were composed
primarily of lymphocytes and macrophages intermingled with a
small number of plasma cells.
In ACA lesions, band-like or patchy perivascular in®ltrates, or
both, were seen primarily in the upper but also in the lower
portions of the dermis (Fig 2b). The in®ltrates were composed of
lymphocytes and macrophages with moderate numbers of plasma
cells. The in®ltrates were most prominent in acute lesions, but were
still present around blood vessels, which were often dilated, in
subacute and chronic lesions. In the chronic stage, thinning of the
epidermis was observed with loss of rete ridges, decreased breadth
of the dermis, and reduction or complete loss of pilosebaceous
units.
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Expression of leukocyte differentiation antigens (IHC) A
semiquantitative determination was made of the frequencies of the
various in¯ammatory cells in a subset of patients from each disease
group (Table I). Among the six patients who had EM alone
without associated symptoms, CD3+ T cells were the predominant
cell type, and they were present in signi®cantly higher numbers
than CD68+ macrophages or CD20+ B cells. Among the six EM
patients who also had associated symptoms, greater numbers of
macrophages were found (Fig 3a); T cells were seen in moderate
number (Fig 3b), and B cells were infrequent. When the two EM
Figure 1. Control experiments for ISH. Hy-
bridization buffer with no probe was applied to a
section obtained from a patient with EM with as-
sociated signs and symptoms. No cytokine-speci®c
cells are visible (a). A section of a biopsy specimen
from normal skin was hybridized to TNF-a anti-
sense riboprobe. Note the minimal constitutive
expression of cytokine mRNA (arrow) (b). A sec-
tion of an in¯amed tonsil was hybridized to IFN-g
antisense riboprobe. Signals are visible as granular
perikaryal staining in T cell rich, extrafollicular
areas (c). Scale bars: 12 mm.
Figure 2. Histopathology of lesional skin in
patients with EM or ACA. In a patient with
EM (a), perivascular in®ltrates of mononuclear
cells are seen throughout the dermis. In a patient
with ACA (b), there is a more diffuse in®ltration
of mononuclear cells in the upper portion of the
dermis. The sections are stained with hematoxylin
and eosin. Scale bars: 100 mm (a), 50 mm (b).
Table I. Expression of leukocyte differentiation antigens based on a score of 0±3 in lesional skin of erythema migrans or
acrodermatitis chronica atrophicansa
CD3 (T cells) CD20 (B cells) CD68 (macrophages)
Erythema migrans without associated symptoms (n = 6) 2.0 (2.0±3.0)bc 1.0 (1.0±2.0) 1.0 (1.0±2.0)
Erythema migrans with associated symptoms (n = 6) 2.0 (2.0±3.0)b 1.0 (1.0±1.0) 3.0 (2.0±3.0)de
Acrodermatitis chronica atrophicans (n = 10) 1.5 (1.0±3.0) 2.0 (1.0±3.0)f 2.0 (2.0±3.0)g
aMedian value (®rst and third quartile values). The percentage of cells positive for a respective leukocyte marker was estimated relative to the total number of in®ltrating
cells: 0, all in®ltrating cells negative; 1, up to a third of all cells positive; 2, between one-third and two-thirds of all cells positive; 3, more than two-thirds of all cells
positive.
bp < 0.05 vs CD20+ cells.
cp < 0.05 vs CD68+ cells.
dp < 0.05 vs CD20+ cells.
ep < 0.05 vs erythema migrans without associated symptoms.
fp = 0.05 vs erythema migrans with associated symptoms.
gp = 0.05 vs erythema migrans without associated symptoms.
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Figure 3. Expression of leukocyte differentia-
tion antigens in lesional skin in patients with
EM or ACA. In a patient with EM who had
associated signs and symptoms, large numbers of
CD68+ macrophages (a) and moderate numbers
of CD3+ T cells (b) are seen in a perivascular
in®ltrate. In a patient with ACA, CD68+ macro-
phages (c) and CD20+ B cells (d) are shown. The
number of macrophages is greater in the EM
lesion than in the ACA lesion. Immunoperoxidase
stained with anti-CD68 (a, c), anti-CD3 (b), or
anti-CD20 (d) antibodies. Scale bars: 50 mm (a, c),
20 mm (b, d).
Figure 4. Expression of cytokine mRNA in
lesional skin in patients with EM with asso-
ciated signs and symptoms. Perivascular in®l-
trates are shown from several representative
patients with in¯ammatory cells that hybridized
with antisense riboprobes for TNF-a (a, c), IFN-g
(b, d), or IL-1b (e). Signals are visible in individual
cells as granular perikaryal staining (arrows). For
comparison, no signals were found when staining
was done with the control sense riboprobe for
IFN-g (f). Scale bars: 25 mm (a, b), 10 mm (c-f).
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groups were compared, macrophages were detected signi®cantly
more often among patients with associated symptoms.
In the ten patients with ACA, macrophages (Fig 3c), T cells, and
B cells (Fig 3d) were found in moderate numbers. As in patients
with EM, reactivity in the ACA patients was more prominent in
the upper portion of the dermis. Most of the cells were observed
within the perivascular in®ltrates except for macrophages, which, in
smaller numbers, appeared in interstitial areas as well. Macrophages
and T cells were found in a scattered pattern and in clusters,
whereas B cells clearly tended to form clusters within the
in¯ammatory in®ltrates.
Expression of cytokine mRNA (ISH) Among the 42 patients
with EM, activation of both pro-in¯ammatory and anti-
in¯ammatory cytokines was found in lesional skin (Tables II,
III). Among the 27 patients who had EM alone without other signs
or symptoms, the major cytokines expressed were the pro-
in¯ammatory cytokine IFN-g and the anti-in¯ammatory cytokine
IL-10 (Tables II, IIII). Twenty-®ve of these patients (93%) had
in¯ammatory cells expressing IFN-g, and a median of 5.7% of the
cells expressed it. Nineteen patients (70%) had in¯ammatory cells
expressing mRNA for IL-10, and a median of 4.1% of the cells
expressed it. Most patients also had a smaller number of
in¯ammatory cells expressing the pro-in¯ammatory cytokines
TNF-a or IL-2, and less than half of patients had a few cells
expressing mRNA for IL-1b, IL-6, or IL-4.
Compared with the 27 patients who had EM alone with no
associated symptoms, the 15 patients who had EM and associated
symptoms had signi®cantly greater expression of macrophage-
derived, pro-in¯ammatory cytokines. All 15 of these patients
(100%) had in¯ammatory cells expressing mRNA for TNF-a
(Fig 4a, c) and IL-1b (Fig 4e), and a median of 6.3% and 3.8%,
respectively, of the cells expressed these cytokines. Similar to the
group without associated symptoms, 14 of the 15 patients with
symptoms (93%) had in¯ammatory cells in EM lesions expressing
IFN-g, and a median of 9.1% of the cells expressed it (Fig 4b, d).
To a lesser degree, anti-in¯ammatory cytokines were expressed as
well. Thirteen patients (87%) had in¯ammatory cells expressing
mRNA for IL-10, and a median of 2.9% of the cells expressed it. In
addition, nine patients (60%) had in¯ammatory cells expressing
mRNA for IL-4, and a median of 1.3% of the cells expressed it.
There was no statistically signi®cant difference between the
expression of cytokine mRNA and the presence or absence of B.
burgdorferi-speci®c DNA in EM lesions. There was also no
signi®cant correlation between the expression of cytokine
mRNA and the duration of EM lesions.
In ACA, a more restricted cytokine pro®le was observed. These
27 patients had very little or no IFN-g expression. Instead, 24 of the
27 patients (89%) had in¯ammatory cells expressing mRNA for
TNF-a, and a median of 4.8% of the cells expressed it (Fig 5a, c);
mRNA for other pro-in¯ammatory cytokines was rarely found.
Nineteen patients (70%) had in¯ammatory cells expressing mRNA
Table III. Number of patients with at least one positive cell for a particular cytokine mRNA in erythema migrans or
acrodermatitis chronica atrophicans
Erythema migrans without Erythema migrans with Acrodermatitis chronica atrophicans
associated symptoms (n = 27) associated symptoms (n = 15) (n = 27)
Pro-in¯ammatory cytokines, number of patients (percentage)
TNF-a 20 (74) 15 (100)a 24 (89)
IL-1b 10 (37) 15 (100)ab 6 (22)
IL-6 7 (26) 10 (67)a 10 (37)
IFN-g 25 (93)c 14 (93)b 6 (22)
IL-2 19 (70)c 12 (80)b 9 (33)
Anti-in¯ammatory cytokines
IL-4 12 (44) 9 (60) 19 (70)
IL-10 19 (70) 13 (87)b 12 (44)
ap < 0.05 vs erythema migrans without associated symptoms.
bp < 0.05 vs acrodermatitis chronica atrophicans.
cp < 0.05 vs acrodermatitis chronica atrophicans.
Table II. Percentage of in¯ammatory cells positive for a particular cytokine mRNA in erythema migrans or acrodermatitis
chronica atrophicans
Erythema migrans without Erythema migrans with Acrodermatitis chronica
associated symptoms (n = 27) associated symptoms (n = 15) atrophicans (n = 27)
Pro-in¯ammatory cytokines, median value (®rst and third quartile values)
TNF-a 2.2 (0.0±6.7) 6.3 (3.8±11.8)a 4.8 (2.9±10.8)b
IL-1b 0.0 (0.0±1.8) 3.8 (1.4±7.1)ac 0.0 (0.0±0.0)
IL-6 0.0 (0.0±1.0) 2.1 (0.0±5.2)a 0.0 (0.0±3.8)
IFN-g 5.7 (2.9±8.6)d 9.1 (3.6±10.6)c 0.0 (0.0±0.0)
IL-2 2.0 (0.0±8.3)d 5.0 (2.9±10.9)c 0.0 (0.0±1.4)
Anti-in¯ammatory cytokines
IL-4 0.0 (0.0±1.5) 1.3 (0.0±3.3) 1.8 (0.0±6.4)b
IL-10 4.1 (0.0±6.0)d 2.9 (0.9±5.9)c 0.0 (0.0±4.0)
ap < 0.05 vs erythema migrans without associated symptoms.
bp < 0.05 vs erythema migrans without associated symptoms.
cp < 0.05 vs acrodermatitis chronica atrophicans.
dp < 0.05 vs acrodermatitis chronica atrophicans.
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for IL-4 and a median of 1.8% of the cells expressed it (Fig 5b, d).
Approximately half of the patients had a few in¯ammatory cells
expressing IL-10 mRNA. This same, restricted pattern of cytokine
expression was seen in patients with acute, subacute, or chronic
lesions.
In both EM and ACA lesions, approximately one to ten
cytokine-positive cells were seen within a given perivascular
in¯ammatory in®ltrate, depending on the frequency of the
cytokine (Figs 4a, b, 5a, b). Serial sections stained for leukocyte
surface markers and then cytokine mRNA expression revealed that
cytokine signals occurred in areas of mononuclear cell in®ltrates.
DISCUSSION
In this study, cytokine patterns were identi®ed in EM and ACA
lesions using ISH with speci®c cRNA probes. This approach had
several advantages. First, a large collection of archival, formalin-
®xed, paraf®n-embedded tissue samples could be used. Second, the
method permits an analysis of cytokine mRNA expression in the
original microenvironment of the skin (Tijssen, 1993; Hoefakker
et al, 1995). Moreover, cytokine induction at the primary site of
infection may be strongly compartmentalized (Hoefakker et al,
1995). This phenomenon has been demonstrated in the cere-
brospinal ¯uid in neuroborreliosis (Wang et al, 1995; Ekerfelt et al,
1997) and in the joint in Lyme arthritis (Gross et al, 1998). Finally,
the anatomic localization of mRNA signals could be determined,
which is especially important in skin where cytokines may be
produced at multiple sites by many different types of cells (Boehm
et al, 1994; Boehm et al, 1995; Sauder and Dytoc, 1997). Thus,
with this method, cytokine-positive cells can be distinguished from
potential background expression in normal tissue, which is a
problem with reverse transcriptase PCR. Although the exact
cellular origin of the cytokine mRNA signals could not be
ascertained without double staining techniques, which were not
done here, serial sections in this study, stained by IHC or ISH,
showed that cytokine-positive cells were con®ned to areas of T cell
and macrophage in®ltrates. Thus, we assume that these cells were
the major source of these cytokines.
ISH has several disadvantages. It is less sensitive than reverse
transcriptase PCR, a potential problem when there are low copy
numbers of mRNA. In our protocol, however, the application of
digoxigenin labeling and microwave oven heating to ISH
techniques (Komminoth, 1992; Lan et al, 1996) provided suf®cient
sensitivity to detect even low levels of mRNA. Second, it is
dif®cult to quantify results by ISH although the cells producing
cytokine mRNA signals can be counted, as was done in this study.
Finally, mRNA expression does not prove that a biologically active
protein is produced, but mRNA expression is thought to provide
an accurate picture of the cytokine responses at sites of
in¯ammation (Brennan et al, 1995).
In this study, patients with EM usually had mRNA expression of
both pro-in¯ammatory and anti-in¯ammatory cytokines in skin
lesions rather than a polarized expression only of Th1 or Th2
cytokines. In EM lesions, IFN-g and IL-10 were often found,
whereas in ACA lesions only TNF-a and IL-4 were found, but
very little or no IFN-g. Spirochetal factors may play a role in this
differential cytokine expression. For example, in experimentally
infected inbred mice (Isogai et al, 1996) and in human
neuroborreliosis (Ekerfelt et al, 1998), different Borrelia genospecies
differentially stimulated the synthesis of cytokines. In another
report, each species had strains with different cytokine induction,
and therefore different cytokine responses could not be ascribed to
particular genospecies (Schulze et al, 1996). In a previous study of
dermatoborrelioses from Styria, the Austrian state in which the
study patients lived, B. afzelii was found to be the causative agent in
74% and B. garinii in 26% of EM patients, and B. afzelii was the sole
pathogen in ACA patients.1 Although the Borrelia species causing
the infection was not determined in either our EM or ACA
patients, we assume that most had B. afzelii infection. Strains of B.
afzelii may differ in the cytokine pro®le that they induce or they
may ®nd a protected niche in ACA but not EM lesions.
The differential cytokine responses observed here could also
relate to the duration of infection. For example, the initial responses
in EM lesions may lead to expression of IFN-g and IL-10, which
may even be produced by the same T cell (Pohl-Koppe et al, 1998).
These cytokines may then induce a broader range of pro-
in¯ammatory and anti-in¯ammatory cytokines accompanied by
the development of associated signs and symptoms. In this study,
EM lesions tended to have been present longer at the time of biopsy
in the patients with associated symptoms than in those without
symptoms, but the differences were not statistically signi®cant.
Furthermore, no statistical correlation was found between duration
Figure 5. Expression of cytokine mRNA in
lesional skin in patients with ACA. Perivascu-
lar in®ltrates are shown from representative pa-
tients with in¯ammatory cells that hybridized with
antisense riboprobes for TNF-a (a, c) and IL-4 (b,
d). Signals are visible in individual cells as granular
perikaryal staining (arrows). Scale bars: 25 mm (a, b),
10 mm (c, d).
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of EM and cytokine mRNA expression. Although one may
wonder whether IFN-g is initially present in ACA lesions, it was
not found even in the lesions of shortest duration.
Host factors are also likely to be important in this differential
cytokine expression. ACA, for example, has been observed mainly
in elderly patients, particularly women, and affects primarily sun-
exposed acral surfaces (AÊ sbrink and Hovmark, 1988). Modulation
of the immune response by age, sex, and ultraviolet radiation may
be factors that in¯uence the course of infection. In B. burgdorferi-
infected C3H mice, ultraviolet B irradiation downregulated the
Th1 response while leaving the Th2 response intact (Brown et al,
1995). Consistent with this ®nding, the current study shows that
ACA patients had very little expression of the Th1 cytokine IFN-g,
but considerable amounts of the Th2 cytokine IL-4.
EM patients in this study were strati®ed according to whether or
not they had associated signs and symptoms, particularly headache,
elevated temperature, myalgias, arthralgias, or fatigue. When these
symptoms were present, a larger number of macrophages and
greater expression of macrophage-derived, pro-in¯ammatory
cytokines was found in EM lesions, including TNF-a, IL-1b,
and IL-6. These cytokines share a number of biologic properties
(Dinarello, 1991), including the induction of a potent acute phase
in¯ammatory response with fever and malaise (Sipe, 1985;
Dinarello et al, 1986; Geiger et al, 1988; Tracey et al, 1988). The
administration of recombinant IL-1 to humans causes headache,
nausea, arthralgias, myalgias, and fatigue (Crown et al, 1991). These
symptoms do not necessarily connote systemic infection with B.
burgdorferi, as only four of the 15 patients with these symptoms had a
clinical picture suggesting spread of the spirochete to other organ
systems. Thus, local production in the skin of these macrophage-
derived cytokines may often account for these associated symptoms.
The different cytokine patterns expressed in EM and ACA
patients are likely to be important in the host's ability to clear the
spirochetal infection. EM, with strong expression of IFN-g and IL-
10, usually resolves spontaneously in weeks to months (Steere et al,
1983b; AÊ sbrink and Olsson, 1985). This response seems to be
critical for spirochetal killing; only rarely is it possible to isolate B.
burgdorferi from sites of spontaneously healed EM lesions (Strle et al,
1995). In contrast, ACA, which seems to lack adequate IFN-g
production, is a chronic progressive infection (AÊ sbrink and
Hovmark, 1988) as evidenced by the cultivation of spirochetes
from these lesions years after disease onset (AÊ sbrink and Hovmark,
1985). Thus, a pro-in¯ammatory response early in the infection,
particularly with IFN-g, seems to be essential in eliminating B.
burgdorferi from the skin, and anti-in¯ammatory cytokines may be
important in the appropriate regulation of this response.
Several murine studies show the importance of pro-in¯amma-
tory cytokines in the control of this spirochetal infection. Although
the initial studies in inbred mice reported severe arthritis in C3H
mice that produced IFN-g and mild arthritis in BALB/c mice that
produced IL-4, these studies did not examine the kinetics of the
response (Keane-Myers and Nickell, 1995; Matyniak and Reiner,
1995). It is now known that B. burgdorferi-infected BALB/c mice
initially produce large amounts of IFN-g, but then switch to IL-4
production (Kang et al, 1997). In contrast, C3H mice produce less
IFN-g initially but continue to have a Th1 response (Kang et al,
1997), which may represent a failure of appropriate immunor-
egulation. Recently, using C3H mice, Zeidner et al (1996) showed
that a pro-in¯ammatory response is critical in the control of early
infection. When the mice were infected with B. burgdorferi and
given recombinant IFN-g, IL-2, or TNF-a, alone or in
combination, the mice were protected from infection. Similarly,
Pride et al (1998) showed that B. burgdorferi-speci®c IFN-g and IL-
2-producing T cells from infected C3H mice signi®cantly reduced
the infection rate in naive C3H recipients. Thus, in both the
human dermatoborrelioses and these murine models, a Th1
cytokine response seems to be critical in eliminating B. burgdorferi
early in the infection.
In summary, mRNA expression of pro-in¯ammatory cytokines,
particularly IFN-g, and anti-in¯ammatory cytokines was found in
EM lesions, which seems to be important in the control and
resolution of this spirochetal infection. In contrast, the restricted
pattern of cytokine expression in ACA lesions, consisting primarily
of TNF-a and IL-4 but little or no IFN-g, may be less effective in
spirochetal killing, which may be a factor in the chronicity of this
skin lesion over a period of years.
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